Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simplified basic immunization after stem cell transplantation
2014-005077-36Phase 4Terminated
- Sponsor
- Region Örebro län
- Start
- Jan 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b conjugate vaccine, tetanus vaccine SSI, Difterivaccin SSI, trivalent inactivated polio vaccine and Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen in Waning vaccine-induced immunity (2 arms), sponsored by Region Örebro län. Primary endpoints: Quantitative IgG antibody level for tetanus, Quantitative IgG antibody level for diphtheria and 2 more. Started Jan 2015; status: terminated.
02
Drugs
diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b conjugate vaccinetetanus vaccine SSIDifterivaccin SSItrivalent inactivated polio vaccineHaemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
03
Conditions
Waning vaccine-induced immunity
Beyond the preview
Go deeper on 2014-005077-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005077-36.